One common concern emergency medicine professionals face is the risk for acute kidney injury (AKI) secondary to the use of intravenous (IV) contrast for CT studies. Currently, emergency medicine ...

Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney ...

Erin Dwyer has been doing a lot of waiting. After a sonogram in December, she found out that she has a growth on her right kidney and had to wait months to see a specialist. Now she’s waiting for a CT ...

Iodine-based contrast material injected intravenously to enhance CT images can be safely used in most patients, according to a study. Of the 80 million or more CT scans performed each year in the ...

Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney ...

Dear Dr. Roach: I'm set to have a CT scan of my lungs with iodine dye. I have hypothyroidism and am on 25 mg of levothyroxine. Should I take the medicine the day of the test? Or should I have the CT ...

Point-of-care creatinine devices ABL800 FLEX, i‑STAT Alinity and StatSensor, which calculate estimated glomerular filtration rate (eGFR), are recommended to assess kidney function to guide decisions ...

Hospitals are just learning about and are very concerned that a shortage of the fluid they use to make CT scans and MRIs more readable may last until late June. For example, The University of Alabama ...

Hospitals across the U.S. are being forced to ration medical scans and procedures after a lockdown in Shanghai hit a plant that produces a widely used contrast dye. The dye, made by General Electric, ...

Jeff Silva walked into his CT scan appointment at Good Samaritan Hospital in Brockton looking for answers. A biopsy and MRI had recently diagnosed his prostate cancer, and his doctors had ordered a CT ...

CHICAGO — Shanghai, China has entered a sixth week of paralyzing COVID lockdowns— with no end in sight. The ripple effect is being felt across the healthcare system in the U.S. Much-needed intravenous ...